全文获取类型
收费全文 | 3564篇 |
免费 | 329篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 58篇 |
妇产科学 | 17篇 |
基础医学 | 211篇 |
口腔科学 | 55篇 |
临床医学 | 491篇 |
内科学 | 495篇 |
皮肤病学 | 68篇 |
神经病学 | 248篇 |
特种医学 | 63篇 |
外国民族医学 | 1篇 |
外科学 | 120篇 |
综合类 | 312篇 |
预防医学 | 913篇 |
眼科学 | 23篇 |
药学 | 610篇 |
3篇 | |
中国医学 | 159篇 |
肿瘤学 | 69篇 |
出版年
2024年 | 18篇 |
2023年 | 106篇 |
2022年 | 209篇 |
2021年 | 274篇 |
2020年 | 189篇 |
2019年 | 184篇 |
2018年 | 137篇 |
2017年 | 132篇 |
2016年 | 133篇 |
2015年 | 110篇 |
2014年 | 208篇 |
2013年 | 203篇 |
2012年 | 144篇 |
2011年 | 156篇 |
2010年 | 150篇 |
2009年 | 127篇 |
2008年 | 110篇 |
2007年 | 112篇 |
2006年 | 127篇 |
2005年 | 77篇 |
2004年 | 74篇 |
2003年 | 55篇 |
2002年 | 60篇 |
2001年 | 60篇 |
2000年 | 39篇 |
1999年 | 46篇 |
1998年 | 33篇 |
1997年 | 28篇 |
1996年 | 46篇 |
1995年 | 48篇 |
1994年 | 45篇 |
1993年 | 41篇 |
1992年 | 40篇 |
1991年 | 49篇 |
1990年 | 50篇 |
1989年 | 29篇 |
1988年 | 49篇 |
1987年 | 45篇 |
1986年 | 50篇 |
1985年 | 36篇 |
1984年 | 43篇 |
1983年 | 5篇 |
1982年 | 16篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 2篇 |
1975年 | 3篇 |
排序方式: 共有3932条查询结果,搜索用时 31 毫秒
21.
Reviewing the definition of "elderly" 总被引:1,自引:0,他引:1
Hajime Orimo Hideki Ito Takao Suzuki Atsushi Araki Takayuki Hosoi Motoji Sawabe 《Geriatrics & Gerontology International》2006,6(3):149-158
Conventionally, "elderly" has been defined as a chronological age of 65 years old or older, while those from 65 through 74 years old are referred to as "early elderly" and those over 75 years old as "late elderly." However, the evidence on which this definition is based is unknown. We have attempted to review the definition of elderly by analyzing data from long-term longitudinal epidemiological studies, and clinical and pathological studies that have been accumulated at the Tokyo Metropolitan Geriatric Hospital and the Tokyo Metropolitan Institute of Gerontology. Our recommendation might be a starting point in developing a strategy for a successful society by reviewing the definition of elderly based on comprehensive evidence in all aspects of social, cultural and medical sciences. 相似文献
22.
L. Marzio F. Di Felice V. Celiberti O. Pieramico L. Grossi M. DiGioacchino B. P. Imbimbo F. Cuccurullo 《European journal of clinical pharmacology》1990,39(4):369-372
Summary To evaluate the influence of the stomach and the cholinergic system on gallbladder contraction induced by physiological stimuli, the reduction in gallbladder volume in 7 healthy volunteers has been studied by real-time ultrasonography after the oral and intraduodenal administration of olive oil, preceded by pretreatment with cimetropium bromide or placebo. After an overnight fast, each subject swallowed 50 ml olive oil or it was administered through a naso-duodenal tube in the proximal duodenum. Cimetropium bromide 5 mg or placebo was given intravenously under double-blind control.After the placebo pretreatment, gallbladder contraction was greater and faster after intraduodenal oil than after oral oil. Cimetropium bromide decreased the extent, velocity and duration of gallbladder contraction induced by intraduodenal olive oil but it only reduced the velocity of the contraction induced by oil given orally.It is concluded that in normal human subjects the stomach modulates the extent and velocity of postprandial gallbladder contraction and that anticholinergic agents antagonize the gastric and duodenal phases of the response of the gallbladder to a meal. 相似文献
23.
M. Sibille N. Deigat V. Olagnier D. Vital Durand R. Levrat 《European journal of clinical pharmacology》1992,42(4):389-393
Summary All the clinical, laboratory and electrocardiographic adverse events detected during 24 Phase I studies in the same unit over a 5 y period are reported here. 430 healthy male volunteers were involved, corresponding to 5488 days of follow-up.The overall incidence of adverse events was 13.5%, with a significant difference between active drug (15.3%) and placebo (7.4%) treatments. There were 69 distinct types of adverse events. Headache was the most frequent symptom (2%). There were severe adverse events in 20 cases (0.36%), with an incidence of 20/430 per subject (4.6%). There were no deaths or life-threatening events.Although the main objective of Phase I studies is to determine the maximum dose tolerated, cause-effect relationships with adverse events are hard to establish, because of the frequency of adverse events with placebo, and because of the limited number of subjects included such studies. 相似文献
24.
25.
P. A. Thürmann C. Sonnenburg-Chatzopoulos R. Lissner 《European journal of clinical pharmacology》1995,49(3):237-242
In two independent trials 10 and 12 healthy volunteers received the novel intravenous immunoglobulin (IVIG) preparations BT 511 and BT 507, respectively. BT 511 contains 5 g human plasma proteins per 100 ml, more than 95% of which are immunoglobulins of the G class (IgG). BT 507 contains in addition 61 IU antibody against hepatitis B surface antigen (anti-HBs)·ml–1. In trial I volunteers received 4.0 ml/kg (n+4) and 8.0 ml·kg–1 (n+6) BT 511 to study the tolerability and the magnitude of the increase in immunoglobulins in plasma as well as their decline over 1 month. After administration of the lower dose, plasma IgG increased from 10.7 to 14.7 g·l–1 directly after the infusion. Following the 8.0 ml·kg–1 dose a more pronounced increase from 12.4 to 21.2 g·l–1 was observed. No adverse events occurred. After 1 month IgG concentrations had almost reached baseline values at 12.2 g·l–1 in the 4.0 ml·kg–1 group, but were still significantly increased at 15.2 g·l–1 after the high dose. There was a linear correlation between the maximal IgG plasma concentration and the subsequent decline of IgG during the 29-day observation period. After administration of BT 507 maximal anti-HBs concentrations of 1778 mU·ml–1 occurred 1.4 h after termination of the infusion. The terminal elimination half-life was 22.4 days, and total clearance and volume of distribution were determined to be 0.122 ml·min–1 and 5.41, respectively. The pharmacokinetic parameters calculated for anti-HBs as an indicator of IgG were in accordance with the pharmacokinetic behaviour of native IgG. 相似文献
26.
Substance P and human nasal mucociliary activity 总被引:2,自引:0,他引:2
Summary Substance P (SP), a potent inflammatory agent, has been found in sensory nerve fibres in the nasal mucosa in several experimental animals as well as in man. It may participate in the inflammatory response as part of the mucosal defence against foreign materials. In experimental animals SP has been found to increase mucociliary in airway mucosa. The present study was performed in order to find out the relationship between topically applied SP and nasal mucociliary function in humans. Thirteen healthy volunteers were challenged with 65 µg SP or placebo in a randomized cross over fashion and mucociliary transport time was determined each time using the saccharine dye test. The dose of SP was chosen after an open dose-response study. No statistically significant change in the mucociliary transport time was found after challenge with SP as compared to placebo. The possible reasons for this are discussed. 相似文献
27.
M Wall 《Pediatric pulmonology》1989,6(2):71-73
The question of whether functional residual capacity (FRC) falls in infants during active sleep has been clouded by studies using different subject groups and techniques for measurements of lung volume and determination of sleep state. Twenty healthy full-term infants within the first week of life participated in the present study. Neurophysiological and behavioral criteria were used to define sleep state, and measurements of FRC were made using a specially constructed closed-circuit helium dilution system. Regularity of respiration was recorded using magnetometers on the chest and a modified respirator monitor. Results showed that no significant changes in FRC occurred, related either to sleep state or to regularity of respiration. In addition, we failed to detect any differences in FRC between the sexes. Pediatr Pilmonol. 1989; 7:71–77 . 相似文献
28.
A. Clancy J. Locke-Haydon R. J. Cregeen M. Ireson J. Ziemniak 《European journal of clinical pharmacology》1987,32(1):103-106
Summary Eight healthy volunteers participated in an open crossover study to assess the effect of a standardised meal on the systemic availability of a single oral dose of fenoldopam mesylate 100 mg. Subjects were studied on four separate occasions, twice fasting and twice fed in randomised, balanced order. Plasma and urine samples were obtained before and at regular intervals up to 25 h post dose. Measurement of fenoldopam (SK&F 82526) and its 8-sulphate metabolite (SK&F 87782) were by means of HPLC-EC analysis. Area under the plasma concentration time curve (AUC) and maximum detected plasma concentration (Cmax) for fenoldopam and SK&F 87782 were significantly reduced whereas time to maximum concentration was significantly increased with food. Using AUC's for fenoldopam and SK&F 87782, mean relative bioavailabilities were 35% and 81% respectively under fed compared with fasting conditions. Twenty-four hour excretion of fenoldopam was significantly reduced with food, but excretion of SK&F 87782 was apparently unchanged. Mean relative bioavailabilities calculated from these data were 83% and 86% respectively. Relatively large inter-subject variability in AUC and Cmax were seen, but intra-subject variability was not marked. Mild symptoms associated with vasodilation were reported on all study days. 相似文献
29.
M. Depré D. J. Margolskee A. Van Hecken J. S. Y. Hsieh A. Buntinx P. J. De Schepper J. D. Rogers 《European journal of clinical pharmacology》1992,43(4):431-433
Summary The disposition of the enantiomers of MK-571 (MK-0679 and L-668,018) following single i. v. doses of MK-571 (L-660,711) was studied in a three way cross-over study in 12 healthy male volunteers. Each volunteer received 75 mg, 300 mg and 600 mg i. v. doses of MK-571 at weekly intervals.The disposition of both enantiomers appeared dose-dependent, since the AUC increased disproportionately faster than the dose. The dose dependency was much more pronounced for L-668,018: its AUC increased 6-fold from the 75 to the 300 mg dose, 16-fold from 75 to 600 mg and 2.7 fold from 300 to 600 mg. For MK-0679, the corresponding increases in AUC were 4.8-, ll-, and 2.3 fold. Regardless of dose, the elimination of L-668,018 was more rapid than that of MK-0679.The disposition of MK-0679 needs to be investigated independently to detect any potential influence of L-668,018 on its disposition. 相似文献
30.
深圳市龙岗区坪地外来工亚健康状态的研究 总被引:5,自引:0,他引:5
目的 :探讨深圳市龙岗区坪地外来工亚健康状况及其影响因素 ,为预防亚健康提供科学依据。方法 :采用统一表格对 12 68深圳市龙岗区坪地外来工进行调查。结果 :外来工的平均年龄为 ( 2 4.96± 6.10 )a ,其亚健康状态总体发生率为 65 .3 0 %,男性亚健康状态发生率为 63 .2 1%,女性为 67.91%,男性和女性之间差异无统计学意义。亚健康状态主要影响因素为 :结婚与否、睡眠时间、工作时间、加班时间以及工作是否有压力和居住环境差等因素 ,而与吸烟、饮酒、文化程度等因素无相关。结论 :深圳龙岗区坪地外来工中普遍存在亚健康状态 ,其发生较高且与工作环境、工作时间、加班时间有密切关系 ,故应引起政府部门及社会各界高度重视 ,加强对外来工的健康保护 相似文献